New molecule kills cancer cells

Researchers at the Hebrew University of Jerusalem have developed a molecule known as NT157 which targets metastatic human melanoma and colon cancer. The molecule has been licensed to Israeli startup TyrNovo for medical trials.

https://www.afhu.org/internationally-acclaimed-researchers-discover-a-double-anti-cancer-agent/news/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *